The global neonatal critical care equipment market size was exhibited at USD 2.25 billion in 2023 and is projected to hit around USD 4.62 billion by 2033, growing at a CAGR of 7.45% during the forecast period 2024 to 2033.
Report Coverage | Details |
Market Size in 2024 | USD 2.42 Billion |
Market Size by 2033 | USD 4.62 Billion |
Growth Rate From 2024 to 2033 | CAGR of 7.45% |
Base Year | 2023 |
Forecast Period | 2024-2033 |
Segments Covered | Type, End-use, Region |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Key Companies Profiled | Drägerwerk AG & Co. KGaA; Cardinal Health; Koninklijke Philips N.V.; Medtronic; Vyaire; BD; GE Healthcare; Ambu A/S; Utah Medical Products, Inc.; Natus Medical Incorporated; Inspiration Healthcare Group plc; Atom Medical Corp.; Fisher & Paykel Healthcare Limited; Masimo; Phoenix Medical Systems (P) Ltd. |
The increasing research for product innovation and the rising number of preterm and low-weight births are expected to drive the growth of the market over the forecast period. The prevalence of LBW and the number of preterm births is constantly rising, which is increasing the demand for care devices. According to WHO, an estimated 15 million newborn children are born preterm, and 20 million or more are born with LBW yearly. These infants are at higher risk of developing congenital disabilities, including retinopathy of prematurity and cerebral palsy. To counter this issue, there is a growing demand for neonatal monitoring and care equipment.
Universities and manufacturers are researching to help resolve product-specific challenges that healthcare professionals face. More noninvasive methods are being adopted, including ultrasound equipment for automatic fetal measurements assisting in labor and tele-ultrasound that is designed to provide at-home ultrasound scans. Considering the high number of neonatal deaths in developing economies, startups are focusing on product innovations. For instance, in August 2021, Resus Right, an Australian startup, received USD 800,000 for its neonatal resuscitation devices for respiratory issues in neonates.
Currently, available monitors in NICUs have modes to incorporate the respiratory rate and airflow, ECG recordings, oxygen saturation over time, temperature, and invasive arterial blood pressure. Advancements in conventional monitoring and imaging devices and equipment for neonates have gained popularity in the past few years and reported increased demand from NICUs. For instance, in May 2023, Sibel Health received the U.S. FDA 510 (k) clearance for its Anne One neonatal and infant monitoring platform. It is a wireless, clinical-grade, and continuous monitoring solution developed specifically for adults, infants, and neonates.
The COVID-19 pandemic negatively impacted the market in 2020. Initially, the lockdown imposed due to the COVID-19 pandemic stretched medical services, disrupting maternity care across the world. The pandemic resulted in a considerable decrease in NICU admissions and newborn resuscitations, which, in turn, negatively impacted the sales of neonatal infant care devices. On the other hand, a high preference for home healthcare is expected to continue post-pandemic, creating new opportunities in the coming years.
The thermoregulation equipment segment held a significant revenue share of 33.0% in 2023 in the neonatal critical care equipment market. With the increasing prevalence of neonatal hypothermia and growing awareness about related high mortality & morbidity, the demand for thermoregulation equipment is expected to increase over the forecast period. According to a research article published in the National Library of Medicine in September 2020, around 32% to 85% of neonates born in hospitals and around 11% to 92% born at home suffer from hypothermia globally, with a higher prevalence in developing economies.
Based on equipment type, the market is divided into thermoregulation equipment, phototherapy equipment, neonatal monitoring devices, respiratory devices, and others. The phototherapy equipment segment is expected to witness the fastest growth over the forecast period due to innovations focusing on their portability and power dependency. Moreover, with the high risk of jaundice in preterm babies, the demand for phototherapy equipment is rising globally. Severe Neonatal Jaundice (SNJ) is among the top 5 to 10 causes of neonatal deaths globally, per the Global Burden of Disease. According to an article published in MDPI in March 2023, the prevalence of SNJ varies from region to region, ranging from 0.73% to 3.34%, with the highest prevalence reported in African & Southeast Asian regions.
The hospitals segment dominated the market with a revenue share of 57.9% in 2023. The segment is further expected to witness the fastest growth over the forecast period. Hospitals that provide neonatal critical care are expanding their treatment capabilities by launching new centers and partnering with other organizations. For instance, in April 2023, the Motherhood Hospitals chain launched virtual Neonatal Intensive Care Units (NICUs) at five locations in India. Expansion of service portfolio by including innovative treatments assists hospitals in strengthening their market position.
Based on end-use, the market is segmented into hospitals, clinics, and others. The clinics segment is expected to witness significant growth over the forecast period. Clinics for neonatal critical care are evolving with patient requirements. Initially, neonatal follow-up was associated with patients discharged from the NICU. However, Neonatal Follow-up Clinics (NFUCs) focus on early intervention and continued monitoring of high-risk infants. Moreover, organizations are providing financial assistance to parents for NICU expenses.
The Asia Pacific region dominated the market with the largest share of 54.35% in 2023. Technological advancements in neonatal critical care equipment and the increasing number of preterm births are anticipated to promote market growth. According to a UNICEF dataset, the overall mortality rate of neonates in South Asia was 22.992 per 1,000 live births in 2021, contributing to 801,694 neonatal deaths in this region in 2021. Hence, the availability of a large patient pool, increasing awareness regarding neonatal care, and the growing presence of global players are likely to drive growth during the forecast period.
The Middle East & Africa region is expected to witness the fastest growth over the forecast period, due to the increasing prevalence of preterm births in Africa. Preterm newborns are found to be prone to infections and diseases. According to an article published in the JAMA Network, most preterm births (around 60%) occur in Africa and South Asia. Hence, these newborns need to be monitored using fetal incubators and fetal monitors. These factors are expected to increase the demand for monitoring devices and equipment, driving technological advancements.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global neonatal critical care equipment market
Type
End-use
Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.3.1. Information procurement
1.3.2. Purchased Database
1.3.3. Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.3.6. Details of Primary Research
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. 1.5 Market Formulation & Validation
1.5.1. Commodity Flow Analysis
1.5.2. Volume Price Analysis
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Research Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Dynamics
3.1.1. Market Driver Analysis
3.1.1.1. Increasing research for product innovation
3.1.1.2. Rising number of preterm and low-weight births
3.1.1.3. Rising technological advancements
3.1.2. Market Restraint Analysis
3.1.2.1. Product recalls
3.1.2.2. Stringent regulatory framework
3.2. Industry Analysis Tools
3.2.1. Porter's Five Forces Analysis
3.2.2. PESTLE Analysis
3.3. COVID-19 Impact Analysis
3.4. Estimated Number of NICUs/NICU Beds at Country Level, 2021 & 2022
Chapter 4. Neonatal Critical Care Equipment Market: Type Estimates & Trend Analysis
4.1. Segment Definitions
4.2. Neonatal Critical Care Equipment Market: Type Segment Dashboard
4.3. Neonatal Critical Care Equipment Market: Type Movement & Market Share Analysis
4.4. Thermoregulation Equipment
4.4.1. Thermoregulation Equipment Market, 2021 - 2033 (USD Million)
4.4.2. Infant Warmers
4.4.2.1. Infant Warmers Market, 2021 - 2033 (USD Million)
4.4.3. Incubators
4.4.3.1. Incubators Market, 2021 - 2033 (USD Million)
4.5. Phototherapy Equipment
4.5.1. Phototherapy Equipment Market, 2021 - 2033 (USD Million)
4.6. Neonatal Monitoring Devices
4.6.1. Neonatal Monitoring Devices Market, 2021 - 2033 (USD Million)
4.6.2. Blood Pressure Monitors
4.6.2.1. Blood Pressure Monitors Market, 2021 - 2033 (USD Million)
4.6.3. Cardiac Monitors
4.6.3.1. Cardiac Monitors Market, 2021 - 2033 (USD Million)
4.6.4. Pulse Oximeters
4.6.4.1. Pulse Oximeters Market, 2021 - 2033 (USD Million)
4.6.5. Capnographs
4.6.5.1. Capnographs Market, 2021 - 2033 (USD Million)
4.6.6. Integrated Monitoring Devices
4.6.6.1. Integrated Monitoring Devices Market, 2021 - 2033 (USD Million)
4.7. Respiratory Devices
4.7.1. Respiratory Devices Market, 2021 - 2033 (USD Million)
4.7.2. Neonatal Ventilators
4.7.2.1. Neonatal Ventilators Market, 2021 - 2033 (USD Million)
4.7.3. Continuous Positive Airway Pressure (CPAP) Devices
4.7.3.1. Continuous Positive Airway Pressure (CPAP) Devices Market, 2021 - 2033 (USD Million)
4.7.4. Oxygen Analyzers and Monitors
4.7.4.1. Oxygen Analyzers and Monitors Market, 2021 - 2033 (USD Million)
4.7.5. Resuscitators
4.7.5.1. Resuscitators Market, 2021 - 2033 (USD Million)
4.7.6. Others
4.7.6.1. Others Market, 2021 - 2033 (USD Million)
4.8. Others
4.8.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Neonatal Critical Care Equipment Market: End-Use Estimates & Trend Analysis
5.1. Segment Definitions
5.2. Neonatal Critical Care Equipment Market: End-Use Segment Dashboard
5.3. Neonatal Critical Care Equipment Market: End-Use Movement & Market share Analysis
5.4. Hospitals
5.4.1. Hospitals Market, 2021 - 2033 (USD Million)
5.5. Clinics
5.5.1. Clinics Market, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Neonatal Critical Care Equipment Market: Regional Estimates & Trend Analysis
6.1. Neonatal Critical Care Equipment Market: Regional Movement Analysis, 2024 & 2033
6.2. North America
6.2.1. North America Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Estimated U.S. Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.2.2.3. Regulatory Framework
6.2.2.4. Competitive Scenario
6.2.2.5. U.S. Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Estimated Canada Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.2.3.3. Regulatory Framework
6.2.3.4. Competitive Scenario
6.2.3.5. Canada Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3. Europe
6.3.1. Europe Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Estimated UK Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.3.2.3. Regulatory Framework
6.3.2.4. Competitive Scenario
6.3.2.5. U.K. Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Estimated Germany Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.3.3.3. Regulatory Framework
6.3.3.4. Competitive Scenario
6.3.3.5. Germany Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Estimated France Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.3.4.3. Regulatory Framework
6.3.4.4. Competitive Scenario
6.3.4.5. France Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Estimated Italy Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.3.5.3. Regulatory Framework
6.3.5.4. Competitive Scenario
6.3.5.5. Italy Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Estimated Spain Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.3.6.3. Regulatory Framework
6.3.6.4. Competitive Scenario
6.3.6.5. Spain Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Estimated Denmark Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.3.7.3. Regulatory Framework
6.3.7.4. Competitive Scenario
6.3.7.5. Denmark Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Estimated Sweden Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.3.8.3. Regulatory Framework
6.3.8.4. Competitive Scenario
6.3.8.5. Sweden Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Estimated Norway Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.3.9.3. Regulatory Framework
6.3.9.4. Competitive Scenario
6.3.9.5. Norway Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Estimated Japan Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.4.2.3. Regulatory Framework
6.4.2.4. Competitive Scenario
6.4.2.5. Japan Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Estimated China Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.4.3.3. Regulatory Framework
6.4.3.4. Competitive Scenario
6.4.3.5. China Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Estimated India Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.4.4.3. Regulatory Framework
6.4.4.4. Competitive Scenario
6.4.4.5. India Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Estimated Australia Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.4.5.3. Regulatory Framework
6.4.5.4. Competitive Scenario
6.4.5.5. Australia Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Estimated Thailand Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.4.6.3. Regulatory Framework
6.4.6.4. Competitive Scenario
6.4.6.5. Thailand Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Estimated South Korea Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.4.7.3. Regulatory Framework
6.4.7.4. Competitive Scenario
6.4.7.5. South Korea Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Latin America
6.5.1. Latin America Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Estimated Brazil Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.5.2.3. Regulatory Framework
6.5.2.4. Competitive Scenario
6.5.2.5. Brazil Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Estimated Mexico Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.5.3.3. Regulatory Framework
6.5.3.4. Competitive Scenario
6.5.3.5. Mexico Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Estimated Argentina Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.5.4.3. Regulatory Framework
6.5.4.4. Competitive Scenario
6.5.4.5. Argentina Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Middle East & Africa
6.6.1. Middle East & Africa Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Estimated South Africa Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.6.2.3. Regulatory Framework
6.6.2.4. Competitive Scenario
6.6.2.5. South Africa Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Estimated Saudi Arabia Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.6.3.3. Regulatory Framework
6.6.3.4. Competitive Scenario
6.6.3.5. Saudi Arabia Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Estimated UAE Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.6.4.3. Regulatory Framework
6.6.4.4. Competitive Scenario
6.6.4.5. UAE Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Estimated Kuwait Neonatal Mortality & Births Attended by Skilled Healthcare Staffs, 2021 - 2023
6.6.5.3. Regulatory Framework
6.6.5.4. Competitive Scenario
6.6.5.5. Kuwait Neonatal Critical Care Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Profiles
7.1.1. Cardinal Health
7.1.1.1. Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Drägerwerk AG & Co. KGaA
7.1.2.1. Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Koninklijke Philips N.V.
7.1.3.1. Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. GE Healthcare
7.1.4.1. Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Medtronic
7.1.5.1. Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Vyaire
7.1.6.1. Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. BD
7.1.7.1. Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Utah Medical Products, Inc.
7.1.8.1. Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Natus Medical Incorporated
7.1.9.1. Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Ambu A/S
7.1.10.1. Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.1.11. Inspiration Healthcare Group plc
7.1.11.1. Overview
7.1.11.2. Financial Performance
7.1.11.3. Product Benchmarking
7.1.11.4. Strategic Initiatives
7.1.12. Atom Medical Corp.
7.1.12.1. Overview
7.1.12.2. Financial Performance
7.1.12.3. Product Benchmarking
7.1.12.4. Strategic Initiatives
7.1.13. Fisher & Paykel Healthcare Limited
7.1.13.1. Overview
7.1.13.2. Financial Performance
7.1.13.3. Product Benchmarking
7.1.13.4. Strategic Initiatives
7.1.14. Masimo
7.1.14.1. Overview
7.1.14.2. Financial Performance
7.1.14.3. Product Benchmarking
7.1.14.4. Strategic Initiatives
7.1.15. Phoenix Medical Systems (P) Ltd.
7.1.15.1. Overview
7.1.15.2. Financial Performance
7.1.15.3. Product Benchmarking
7.1.15.4. Strategic Initiatives
7.2. Company Categorization
7.3. Company Market Position Analysis
7.4. Strategy Mapping
7.5. List of Few Distributors/Suppliers, by Region
Chapter 8. Recommendations/Key Market Insights